89R13930 AND-D     By: Menéndez S.B. No. 2470       A BILL TO BE ENTITLED   AN ACT   relating to the requirements for the labeling and dispensing of a   prescription drug or biological product.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 562.006, Occupations Code, is amended by   amending Subsections (b) and (f) and adding Subsection (g) to read   as follows:          (b)  In addition to the information required by Subsection   (a), the label on the dispensing container of a drug or biological   product dispensed by a Class A or Class E pharmacy must [indicate]:                (1)  indicate:                      (A)  the name, address, and telephone number of   the pharmacy;                      (B) [(2)]  the date the prescription is   dispensed;                      (C) [(3)]  the name of the prescribing   practitioner;                      (D) [(4)]  the name of the patient or, if the drug   or biological product was prescribed for an animal, the species of   the animal and the name of the owner;                      (E) [(5)]  instructions for use;                      (F) [(6)]  the quantity dispensed;                      (G) [(7)]  if the drug or biological product is   dispensed in a container other than the manufacturer's original   container, the date after which the prescription should not be   used, determined according to criteria established by board rule   based on standards in the United States Pharmacopeia-National   Formulary; and                      (H) [(8)]  any other information required by   board rule; and                (2)  include, in a format accessible to the patient   through a mobile Internet application or assistive technology   electronic device available to the patient at no cost, the   information described by Subdivision (1) and information regarding   potential side effects and contraindicated medications.          (f)  The [board shall adopt rules requiring the] label on a   dispensing container must [to] be in plain language and printed in   Times New Roman with a minimum of 12-point [an easily readable] font   size [for the consumer].          (g)  A pharmacist at a Class A or Class E pharmacy shall, on a   patient's request, provide to the patient a large-print data sheet   containing:                (1)  the information required under Subsection (b)(1)   to be on the label on a dispensing container of a drug or biological   product dispensed to the patient; and                 (2)  information regarding potential side effects and   contraindicated medications for the drug or biological product   dispensed to the patient.          SECTION 2.  Not later than January 1, 2026, the Texas State   Board of Pharmacy shall adopt any rules necessary to implement the   changes in law made by this Act.          SECTION 3.  The changes in law made by this Act apply only to   a drug or biological product dispensed on or after March 1, 2026. A   drug or biological product dispensed before March 1, 2026, is   governed by the law in effect immediately before the effective date   of this Act, and the former law is continued in effect for that   purpose.          SECTION 4.  This Act takes effect September 1, 2025.